Page last updated: 2024-09-03

mk 0663 and Asthma

mk 0663 has been researched along with Asthma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daham, K; Dahlén, B; Dahlén, SE; Eldh, M; Gabrielsson, S; Larssen, P; Martinez-Bravo, MJ; Sánchez-Vidaurre, S; van Hage, M1
Blanca, M; Corzo, JL; Gallego, C; Mayorga, C; Muñoz, C; Requena, G; Torres, MJ; Urda, A; Zambonino, MA1
Balgoma, D; Billing, B; Daham, K; Dahlén, B; Dahlén, SE; FitzGerald, GA; Henriksson, E; James, A; Kupczyk, M; Lindeberg, A; Wheelock, CE1
Cardoso, C; Hoffken, G; Koschel, D; Leucht, V1
Al-Herz, AA; Al-Qhouti, BI; Khadadah, ME; Muqim, AT; Nahar, IK; Shehab, DK; Uppal, SS1
Ahmed, I; El Gaafary, M; El Miedany, Y; Youssef, S1

Trials

4 trial(s) available for mk 0663 and Asthma

ArticleYear
RNA-containing exosomes in induced sputum of asthmatic patients.
    The Journal of allergy and clinical immunology, 2017, Volume: 140, Issue:5

    Topics: Adult; Allergens; Asthma; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Exosome Multienzyme Ribonuclease Complex; Female; Humans; Male; Middle Aged; Sputum; Young Adult

2017
Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.
    The Journal of allergy and clinical immunology, 2014, Volume: 134, Issue:2

    Topics: Adult; Allergens; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Eosinophils; Etoricoxib; Female; Forced Expiratory Volume; Humans; Inflammation; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Prostaglandins; Pyridines; Sputum; Sulfones

2014
The use of etoricoxib in patients with bronchial asthma associated with aspirin sensitivity.
    Saudi medical journal, 2006, Volume: 27, Issue:1

    Topics: Aspirin; Asthma; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Etoricoxib; Humans; Pyridines; Sulfones

2006
Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation Tests; Cross Reactions; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Dyspnea; Etoricoxib; Female; Forced Expiratory Volume; Humans; Male; Peak Expiratory Flow Rate; Pyridines; Rheumatic Diseases; Single-Blind Method; Sulfones

2006

Other Studies

2 other study(ies) available for mk 0663 and Asthma

ArticleYear
Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    The British journal of dermatology, 2014, Volume: 170, Issue:3

    Topics: Adolescent; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Child; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Drug Substitution; Etoricoxib; Female; Humans; Male; Meloxicam; Pyridines; Retrospective Studies; Sulfones; Thiazines; Thiazoles; Urticaria

2014
Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma.
    Allergy, 2008, Volume: 63, Issue:8

    Topics: Anaphylaxis; Aspirin; Asthma; Cyclooxygenase Inhibitors; Etoricoxib; Female; Humans; Middle Aged; Pyridines; Severity of Illness Index; Sulfones

2008